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ABSTRACT  
Metastasis is the most common cause of death for cancer patients. To fully understand the 
steps involved in metastatic dissemination, in vivo models are required, of which murine ones 
are the most common. Therefore preclinical imaging methods such as magnetic resonance 
imaging (MRI) have mainly been developed for small mammals, and their potential to monitor 
cancer growth and metastasis in non-mammalian models is not fully harnessed. We have here 
used MRI to measure primary neuroblastoma tumour size and metastasis in a chick embryo 
model. We compared its sensitivity and accuracy to end-point fluorescence detection upon 
dissection.  
Human neuroblastoma cells labelled with GFP and micron-sized iron particles (MPIOs) were 
implanted on the extraembryonic chorioallantoic membrane of the chick at E7. T2 RARE, T2 
weighted FLASH as well as time-of-flight MR angiography imaging was applied at E14. MPIO 
labelling of neuroblastoma cells allowed in ovo observation of the primary tumour and tumour 
volume measurement non-invasively. Moreover, T2 weighted and FLASH imaging permitted 
the detection of small metastatic deposits in the chick embryo, thereby reinforcing the potential 
of this convenient, 3R compliant, in vivo model for cancer research. 
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BACKGROUND 
Metastasis accounts for 90% of cancer deaths (1), yet it is one of the most poorly understood 
aspects of tumour progression. In order to reduce metastasis associated mortality, it is crucial 
to understand how, when and where metastasis occurs. However, small size, heterogeneity 
and large dispersal of disseminated cancer cells, combined with the limited sensitivity and 
spatial resolution of current clinical imaging methods, make their early and reliable detection 
challenging. Metastatic dissemination is a complex process involving several steps from the 
initial detachment of cells from the primary tumour, diffusion within the surrounding stromal 
tissue, degradation of the extracellular matrix and intravasation into the blood stream. Once 
in the circulatory system, tumour cells not only have to survive the hostile environment, but 
also attach to the endothelial cells of the vessel wall, extravasate in the extravascular tissue 
and proliferate in the metastatic site to form secondary tumours (2). Although many of these 
steps have been studied at a molecular level in vitro, visualisation of the dynamic events in 
vivo remain elusive.  
Currently used methods to detect the presence of metastasis in vivo in experimental studies 
rely mostly on endpoint measurements and require the termination of the experiment and 
organ dissection. Modern imaging modalities such as magnetic resonance imaging (MRI), 
positron emission tomography (PET) or bioluminescence imaging (BLI) allow non-invasive 
and longitudinal imaging of metastatic dissemination in whole organisms. In addition, MRI 
provides enhanced soft tissue contrast, three dimensional anatomical information and high 
spatial resolution. While the detection of primary tumours with MRI is already a routine 
practise, finding metastasis is more challenging as the metastatic cell population is 
heterogeneous and usually consists of single cells or a small group of malignant cells present 
in various tissue types, which makes their detection difficult. The use of contrast agents like 
iron oxide nanoparticles or Gadolinum-based agents for cell labelling can enhance contrast 
and thus detection limit. Iron oxide particles cause a distortion in the magnetic field leading to 
a change in T2/T2* relaxation and are mainly used to generate hypointense contrast on MRI (3, 
4). While a broad range of iron oxide particles are available for cell tracking, micron-sized iron 
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particles (MPIOs) are of special importance as they are not only taken up efficiently and rapidly 
by cells but also enable prolonged imaging due to their ability to label cells with a single particle 
only (5-7). Using contrast agents, metastasising cells could be detected in the lymph nodes 
(3, 8-10), liver (11-13) and brain (14) of rodents. Foster et al. reported the detection of 
approximately 100 MPIO labelled cells after direct implantation of melanoma cells in the lymph 
node (3). Even detection at single cell level was observed as small metastastic deposits could 
be found in livers post mortem (12) and in the brain after injection into the left ventricle of the 
heart (14). 
Whilst rodents constitute the most widely used preclinical model for studying tumour 
development and metastasis, the chick embryo is a versatile 3R compliant model that is readily 
accessible in or ex ovo, nutritionally self-sufficient, cost-efficient and phylogenetically more 
similar to mammals than several other models of replacement, such as the zebrafish or 
nematode worm. The main advantage, when models for tumour formation are considered, is 
the accessibility of its chorioallantoic membrane (CAM), a highly vascularised extraembryonic 
membrane that is located directly beneath the eggshell. Thus, tumour cells can be engrafted 
easily, non-invasively and in the absence of an ‘interfering’ immune system, since the chick 
embryo is immunodeficient at earlier stages of development, when cells are implanted. Within 
days, tumour formation occurs and, in the case of aggressive tumours, metastasising cells 
can colonise the host’s organs via haematogenous metastasis (15). However, despite all the 
advantages of the chick embryo, its potential has not been fully exploited so far. One reason 
for this might be the difference in protocols required for the successful MR imaging without 
motion artefacts. While the topical application of anaesthetic agents can be used to achieve 
motionless imaging, it can impair the embryo’s survival and thus render this method 
impractical for longitudinal imaging. Cooling the embryo on the other hand has been 
successfully used for repeated MR imaging at different embryonic stage (16, 17). Together, it 
makes the chick embryo model an attractive alternative for in vivo animal experiments.  
We evaluated the advantages and limitations of MRI to study metastatic dissemination of 
neuroblastoma in the chick embryo, as a preclinical model. We have shown previously that 
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we can induce metastasis in vivo by preculturing neuroblastoma cells in hypoxia or by treating 
with the hypoxia mimetic drug dimethyloxalylglycine (DMOG), where cells metastasise in 52% 
and 75% of cases, respectively (15). Whilst MRI has previously been used to monitor tumour 
growth in the chick embryo (17), we here investigated the feasibility of MRI to detect metastatic 
deposits of MPIO labelled neuroblastoma cells in the chick embryo.   
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METHODS 
Cell culture 
The human NB line SK-N-AS (ECACC No. 94092302) was grown in Minimal Essential 
Medium supplemented with 10% (v/v) foetal calf serum and 1% (v/v) non-essential amino 
acids (both Life Technologies) and maintained in a humidified incubator at 37°C, 5% CO2. For 
hypoxic studies, cells were maintained at 37°C, 5% CO2 and 1% O2 (Don Whitley Scientific – 
Hypoxystation-H35). 
 
Stable cell line generation and cell labelling 
Lentiviral particles were produced with the transfer vector pLNT-SFFV-EGFP (18) as 
described previously (6). For cell labelling 2 × 106 SK-N-AS cells were seeded in a T-75 flask 
and allowed to grow for 24 h. Then 20 µM of Suncoast Yellow Encapsulated Magnetic 
Polymers (Bangs Beads, Stratech Scientific, Suffolk, England) were added directly to the 
complete culture medium and cells were allowed to grow for further 48 h. After the labelling 
period, the cells were carefully washed with phosphate buffered saline (PBS) to remove 
excess contrast agent, harvested and used for in vivo studies. Stability of the bang beads over 
time and their remaining numbers in cells upon multiple cycle of cell division was previously 
tested (6). 
 
Primary tumour, experimental and spontaneous metastasis assay 
For the observation of the primary tumour, CAM implantation at E7 was performed as 
described previously (19). In brief, fluorescent (GFP) and MPIO labelled SK-N-AS cells were 
harvested and 1 × 106 cells/µl were resuspended in serum free media. CAM implantation was 
achieved by transferring 2 µl of the cell suspension into the CAM membrane fold created by 
careful laceration of White Leghorn chicken embryos.  
For the observation of cells directly injected in the chick organs, fluorescent and MPIO 
labelled SK-N-AS cells were harvested and 1 × 105 cells/µl resuspended in serum free media 
and 0.15% (v/v) Fast green (Sigma-Aldrich). Cell implantation was achieved by injecting 3 µl 
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of the cell suspension into the brain of White Leghorn chicken embryos in ovo at E7 using a 
micro-capillary pipette.  
For the observation of spontaneous metastasis CAM implantation at E7 was performed as 
described above for primary tumour formation using hypoxic preconditioned neuroblastoma 
cells. In brief, fluorescent (GFP) labelled SK-N-AS cells were preconditioned in 1% O2 for 3 
days. MPIO labelling took place 48h prior harvesting. Cells were harvested and 1 × 106 cells/µl 
were resuspended in serum free media. CAM implantation was achieved by transferring 2-
10 µl of the cell suspension into the CAM membrane as explained above. 
After cell implantation, eggs were maintained at 37 °C and 40% humidity (Ovo Easy 380, 
Brinsea) until E11 or E14 and all animal work followed UK regulations (Consolidated version 
of ASPA 1986). For MR scanning, embryos were removed from the incubator at E11 or E14, 
cooled at 4 °C for 60 min and then imaged. The cooling protocol was previously described by 
Zuo et al., however, here the same cooling duration was used for both E11 and E14, as it was 
enough, in our room temperature conditions, to avoid chick movement and to keep the egg 
cold upon imaging. In the case of time-of-flight (ToF) angiographic MRI, embryos were not 
cooled but anaesthetised with 3.6 mM Ketamine in 500 µl of PBS (Sigma-Aldrich) dropped 
directly onto the CAM prior to MR imaging. The protocol for ketamine application was 
optimised by using different concentration of ketamine (data not shown). The application of 
3.6 mM Ketamine in 500 µl of PBS resulted in MR imaging that was free of motion artefacts 
for 30 mins (ToF scanning time was 12 min). Whilst the embryos recovered well after 
anaesthesia, we cannot exclude an impact on long-term survival as mentioned by Zuo et al. 
(17).  
 
Fluorescent detection of tumour and metastatic deposits.  
Following MRI, a standard fluorescent stereo microscope (Leica M165-FC) was used to 
image primary tumours and metastatic deposits. Tumours were removed from the CAM and 
were imaged from three different perspectives (dorsal, ventral and lateral). Following removal 
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of primary tumours from the CAM, embryos were dissected. Organs were removed and tumour 
cells and / or metastatic deposits identified by fluorescence.  
Subsequently, tumour and organ samples were fixed for up to 12 h in 4% formaldehyde for 
the preparation of 10 µm thick frozen sections. Frozen tissue slices were stained with Hoechst 
and analysed with an epi-fluorescent microscope (Axio ObserverZ1, Zeiss). A representative 
sagittal MRI slice was correlated with the section of the region of tumour or metastatic deposit.  
 
Tumour volume calculation 
By microscopy 
Excised tumours were imaged from three different perspectives (dorsal, ventral and lateral). 
Average tumour volume was calculated as previously described (15) using 𝑉 =
 4 3 × 𝜋 × 𝑙 × ℎ × 𝑑⁄ , where l is length, h is height and d is depth. The volume of tumours 
extracted from 8 chick embryos was analysed.  
 
By MRI 
T2 weighted (T2W) images were used for tumour volume calculation. The tumour area was 
measured with ImageJ (Wayne Rasband) in each slice and tumour volume was calculated 
using 𝑉 = (𝑡 + ℎ) ∑ 𝐴𝑖
𝑁
𝑖=1  , where N is the number of slices, Ai the area of the ROI 
encompassing the tumour, h the slice gap and t the slice thickness (20). The volume of 
tumours extracted from 8 chick embryos was analysed.  
 
 
In ovo MRI 
MR data were acquired with a Bruker Avance III spectrometer interfaced to a 9.4T magnet 
(Bruker Biospec 90/20 USR) using a 74 cm transmit-receive resonator coil. Sagittal images of 
the chick embryos were acquired using following sequences: (1) high resolution TurboRARE 
T2 weighted (T2W)  images with the following parameters: field of view 45 × 35 mm, matrix 
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size 512 × 398 (256 × 198 for Figure 1A-C), slice thickness 0.4 mm (0.5 mm for Figure 1A-C), 
slice gap 0.3 mm, effective TE 35 ms, TR 7822 ms (6703 ms and 7262 ms for Figure 1A and 
Figure 1B/C, respectively), averages 5, slices 70 (60 and 65 for Figure 1A and Figure 1B/C, 
respectively), scan time 31 min 56 s (13 min 24 s and 14 min 31 s for Figure 1A and Figure 
1B/C, respectively); (2) T2* weighted (T2*W) images using a FLASH sequence with the 
following parameters: field of view 45 × 35 mm, matrix size 512 × 398, slice thickness 0.4 mm, 
slice gap 0.3 mm, effective TE 6.88 ms, TR 1135 ms, averages 3, flip angle 30o , slices 70, 
scan time 22 min 35 s; (3) angiography using a ToF sequence with following parameters: field 
of view 45 × 35 mm, matrix size 512 × 398, slice thickness 0.4 mm, slice gap 0.3 mm, effective 
TE 3.1 ms, TR 13 ms, averages 2, flip angle 80o , slices 70, scan time 12 min 4 s. 
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RESULTS 
 
T2W imaging of chick embryos allows observation of tumourigenesis and embryonic 
development.  
Fluorescently labelled (GFP) neuroblastoma cells were implanted on the CAM at E7 and 
tumour formation was assessed by MRI. Representative images from T2W multi-slice MRI 
scans obtained at E11 and E14 are shown in Figure 1A and B, respectively. Allantois, yolk 
sack and chick embryo organs such as liver, kidneys and heart can be clearly identified and 
studied over time. The cooling of the embryos at 4 °C for 60 min prior to imaging reduced their 
movement for up to 60 min allowing motionless imaging. Tumours grown on the CAM can be 
easily identified by MRI (Figure 1C). Primary tumour dissection with a fluorescent microscope 
revealed that location and morphology of the tumour are in good correlation with the images 
acquired by MRI (Figure 1D).  
 
MPIO labelling facilitates tumorigenesis observation and allows tumour volume 
measurement. 
To investigate whether MPIO labelling enhances the detection of primary tumours, GFP-
expressing neuroblastoma cells were labelled with red fluorescent MPIOs for 48 h prior to 
CAM implantation. MPIO uptake was efficient as all cells contained multiple MPIOs 24 h post 
labelling (Figure 2A). MPIO labelled cells successfully formed tumours on the CAM and signal 
from GFP as well as MPIOs could be detected by fluorescence (Figure 2B). Tumour formation 
was then assessed by T2W and T2*W fast low angle shot (FLASH) MRI scans. Using FLASH, 
areas containing cells labelled with MPIOs should experience an enhanced signal loss 
compared to other areas, such as blood vessels or tissue. Representative images from T2W 
and T2*W FLASH scans obtained at E14 show that, as with unlabelled cells, tumours could be 
readily identified in the MR scans (Figure 2C). Tumours formed from MPIO labelled cells, 
however, displayed a much stronger signal loss, which is expected given their iron oxide load. 
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Primary tumour dissection revealed that location and morphology of the tumour were 
comparable to the images acquired by MRI (Figure 2B). Fluorescent images of frozen tumour 
sections revealed a homogenous distribution of MPIOs within the tumour (Figure 2D). Only a 
fraction of cells still contained MPIOs, which was expected due to extensive cell proliferation 
during tumour development in vivo and consequently, progressive dilution of the label between 
daughter cells. MPIOs were only observed in GFP-labelled tumour cells and not in the 
surrounding chick tissue.  
In order to determine whether MRI can also be used to determine tumour volume, tumour 
areas on sagittal T2W MRI slices displaying the primary tumour were measured and calculated 
as described in the method section. Different amounts of cancer cells were implanted in order 
to compare a range of tumour sizes and observe whether the two methods relate for small as 
well as large tumours. In addition we also compared labelled cells with unlabelled ones. 
Tumour volume estimates were then compared to those obtained from tumour excision and 
microscopy and were comparable with a difference of 6.19% and 5.95% for tumours formed 
by unlabelled and labelled cells, respectively (Figure 2E). The slight dissimilarity between the 
two methods can be explained by the difference in volume calculation. While the volume 
measured in images obtained by microscopy assumes that the tumour is a spherical object, 
MRI allows a more precise estimation as the area of each slice displaying a tumour is 
considered. Whilst it was easier to see the tumours when they were labelled with MPIO, it did 
not drastically change the ability to detect primary tumours and it had no impact on tumour 
volume measurements. Thus, MRI can easily be used to study the presence, progression and 
volume of tumours non-invasively over time, in contrast to fluorescence microscopy, which 
necessitate tumour excision from the CAM.     
 
MPIO labelling combined with T2W and FLASH imaging allows detection of metastasis. 
To first investigate whether MPIO labelling enables the detection of cells within the chick 
embryo organs, 3 × 105 GFP-expressing and MPIO labelled neuroblastoma cells were directly 
injected into the brain of the chick embryo at E7 and analysed at E14. Representative images 
MR imaging of metastasis 
12 
 
from T2W and T2*W FLASH scans obtained at E14 are shown in Figure 3A. A small region 
(2 x 1 mm) of signal loss can be observed in the brain indicating the presence of MPIO labelled 
tumour cells. Size, shape and location of the cell cluster correlate well with the fluorescent 
signal obtained by subsequent fluorescence microscopy and tissue analysis (Figure 3B). Like 
in the primary tumour growing on the CAM, MPIOs were homogenously distributed among the 
cell population, with a great proportion of the cells not containing MPIOs anymore.   
We further evaluated whether MPIO labelling enables the detection of spontaneous and 
smaller metastasis by using a spontaneous metastasis model in the chick embryo (15). We 
have previously shown that we can control metastasis of neuroblastoma cells by hypoxic 
preconditioning (15). While cells grown in normoxia are capable of tumourigenesis but not of 
metastatic invasion, cells grown in hypoxia (3 days in 1% O2) metastasise in 52% of the cases 
from the primary tumour into the chick embryo organs. Whilst such metastatic phenotype was 
observed as an end point measurement upon chick organs dissection, the detection of 
metastasis in the chick embryo using imaging modalities has not yet been reported. GFP-
expressing and MPIO labelled neuroblastoma cells were cultured under hypoxia, implanted 
on the CAM at E7 and their metastasis into chick tissues was assessed at E14, using T2W 
and T2*W FLASH scans (Figure 3C). FLASH MRI was applied in order to distinguish the 
regions of signal loss caused by small blood vessels, haemorrhagic areas, air-tissue interfaces 
like the pancreas or areas devoid of proton signal such as the lungs from potential 
neuroblastoma metastasis. Several small areas of signal loss were observed in the kidneys of 
chick embryos. Arrows indicate the areas where signal loss with T2*W FLASH was maintained 
or increased (for quantification of the signal loss, see Supplemental Figure 1), indicating the 
presence of metastasising labelled cells. Organ dissection and analysis by fluorescence 
microscopy confirmed the presence of several metastatic deposits in the kidney as shown in 
Figure 3D. The metastatic deposits consisted of up to 12 cells and up to 4 MPIOs. Thus even 
very small metastasis could be detected by MRI. However, their identification was not trivial 
given their small size in the inherent low MR signal of the kidney. An exact registration between 
MRI and histology was not possible as the MRI data acquired were non-isotropic, therefore 
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anatomical landmarks were used and provided a good correlation between imaging findings 
and histological staining. 
 
To be able to differentiate the small metastatic deposits from the blood vessels, we applied 
time-of-flight MR angiography (ToF MRA). This allowed signal loss caused by small blood 
vessels to be distinguished from potential metastasis more effectively than using FLASH 
alone. As ToF is dependent on the influx of fresh unsaturated blood, chick movement reduction 
was necessary. We tested two methods for reducing embryo movement: ketamine 
anaesthesia and embryo cooling. Cooling the embryos resulted in a reduced blood flow 
making successful ToF acquisition unfeasible. Therefore, ketamine anaesthesia was used. 
Representative ToF images were overlaid with imaged from T2W and T2*W FLASH scans 
obtained at E14 are shown in Figure 3E. Although ToF MRA allows the detection of bigger 
blood vessels, the small and very fine vessels in the kidney for example as well as other 
hypointense areas such as the gastrointestinal tract could not be resolved with the current 
acquisition protocol that was optimized to keep the embryos viable limiting the ability to detect 
small metastasis in this model.  
Taken together, we have demonstrated that primary tumour formation on the CAM can be 
easily detected in the chick embryo model. Tumour cells within the organs of the chick embryo 
can be also detected, however 12 cells (labelled with 1 remaining MPIO) seemed to constitute 
the lower limit for a reliable detection and we anticipate that larger metastases are required to 
provide a more robust signal.  
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DISCUSSION 
Much of our current understanding about the complex metastatic process comes from modern 
imaging techniques. While each imaging modality comes with advantages and limitations, MRI 
offers detailed three dimensional anatomical information and high resolution over time in a 
non-invasive manner. In agreement with others, we show here, that MRI is a powerful imaging 
modality for the study of tumour progression (17, 21) and embryonic development (16, 22-26)  
in the chick embryo. Compared to optical imaging, it can be used to detect the presence of 
tumours even when they are hidden beneath the egg shell and allows the non-invasive study 
of tumour progression and volume over time.  
The main aim of this study was to determine whether MRI can also be used to detect the 
presence of metastasis non-invasively in the chick embryo. In order to observe metastatic 
dissemination, neuroblastoma cells were labelled with MPIOs as contrast agents. The 
labelling of cancer cells with MPIOs did not alter tumour formation on the CAM. While it did 
not offer significant advantages for primary tumour detection compared to unlabelled cells, it 
was necessary for small metastasis detection in the chick embryo organs. We initially tried to 
detect large clusters of cells, administered directly to the brain of the chick embryo, which 
resulted in a substantial loss of signal and thus in a robust detection of cancer cells. This 
suggests that cancer lesions of about 2 mm are detectable in the chick embryo, a size that is 
smaller than the MRI detection limit of metastasis reported being 10-20 mm in rodents (27). 
This finding is in agreement with others that have used SPIONs to successfully detect 
micrometastases in lung, lymph node and brain in mice (3, 14, 28). Using SPIONs and 
hyperpolarized 3He MRI, Branca et al. could detect micrometastasis of 0.3 mm in the lung of 
mice (28), while Foster et al. could detect 100 MPIO labelled cells by MRI after injecting them 
directly into the lymph node of mice (3) and Heyn et al. used SPION labelled breast cancer 
cells to detect a small number of cells in the brain of mice (14). We have also shown previously 
that MRI can be used to reliably detect cell clusters of 5 x 104 SPION labelled cells in the brain 
ex vivo (6). Apart from SPIONs, other contrast agents have also been used for imaging 
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metastasis. In mice, Zhou et al. could detect breast cancer metastases of less than 0.5 mm in 
different organs such as the lung, liver, lymph node, adrenal gland and bone using a 
gadolinium based contrast agent (29). Xue et al. developed a protein-based contrast agent 
that enabled them to image early liver metastases as small as 0.24 mm in diameter after tail 
vein injection of uveal melanoma cells into mice (27). It should be noted that although MPIO 
labelling aids the detection of metastasised cells by enhancing their contrast, the division of 
cancer cells will lead to an expected loss of signal. The use of micron-sized contrast agents, 
as used here, offer the advantage that at least one of the daughter cells could potentially retain 
enough iron to display a T2-shortening effect, which would be lost in the case of nano-sized 
particles, where a 50% reduction in signal intensity at every cell division would quickly render 
them undetectable. However, this means that in a rapidly dividing cancer type, a proportion of 
unlabelled cells exists that thus will not be detectable.  
 
Compared to mice, the chick embryo is a cost effective and convenient model, complying with 
the 3Rs by replacement of animal use. At E14, the metastatic deposits of neuroblastoma cells 
consist of only few cells, hence we wanted to determine if MRI could be used for their 
identification. We could observe signal reduction caused by a single MPIO particle and thus 
identify very small clusters of metastasised cells in the kidneys. However, the signal observed 
in the chick’s internal organs, including the kidney is inherently low, hence reliable detection 
of metastatic cells remains challenging with a potential of increased false positives. A 
confirmatory method, such as dissection, was needed to confirm the presence of such small 
metastatic deposits. These detection difficulties can be partially overcome by applying special 
techniques, such as ToF MRA, which we used here. Although ToF MRA enabled us to identify 
larger blood vessels, very small blood vessels couldn’t be resolved and consequently failed to 
facilitate the reliable detection of small metastasis in organs such as the kidney. Hence we 
would recommend ToF for cases where cells consistently metastasise to a defined region, 
which could then be scanned using a narrower field of view with a shorter scan time. Thus, 
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the detection of metastasis of tumour types that disseminate either in organs of minimal signal 
loss, such as the brain or disseminate in bigger cell clusters, is more appropriate to this model.  
In conclusion, we report that MRI is a suitable and highly sensitive imaging modality to image 
tumourigenesis in vivo using a chick embryo. We could, for the first time, identify metastatic 
deposits in the chick embryo by MRI. However, for reliable detection, we observed that 12 
cells was the lower limit of detection. Whilst this means that this approach cannot be used to 
detect the onset of metastasis from a single cell, the small metastases observed was still 
remarkable, with the potential of providing longitudinal view of disease progression in the same 
animal non-invasively, particularly of primary tumours generated in areas such as the CAM or 
injected cells in the brain.   
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LIST OF ABBREVIATIONS  
BLI  bioluminescence imaging  
CAM  chorioallantoic membrane  
DMOG  Dimethyloxalylglycine  
FLASH fast low angle shot  
H&E  haematoxylin and eosin  
MPIOs  micron-sized iron particles 
MRI  magnetic resonance imaging  
PBS  phosphate buffered saline  
PET  positron emission tomography  
ToF MRA time-of-flight MR angiography 
T2W  T2 weighted 
T2*W   T2* weighted  
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FIGURE LEGENDS 
Figure 1: T2W images of tumours growing on the CAM 
A and B) Representative sagittal T2W MR images of E11 (A) and E14 (B) chick embryo in 
ovo. Egg compartments like albumen (1), yolk (2) as well as chick embryo organs like brain 
(3), eyes (4), kidneys (5) heart (6) liver (7) and gizzard (8) can be identified. C) Representative 
sagittal T2W MR images of embryonated chicken egg at E14 in ovo. Extraembryonic tumour 
can be identified on top of the CAM (zoom in inset) and correlates with fluorescent image (D). 
Due to the anatomy of the egg the primary tumour is not always located above the chick 
embryo and thus the chick embryo does not always appear in the same sagittal slice as the 
one showing the primary tumour. D) The same tumour than in C) was imaged with 
fluorescence microscopy. The picture is a representative image of the tumour formed by GFP-
expressing neuroblastoma cells. Scale bars represents 1000 µm. 
 
Figure 2: T2W and T2*W FLASH images of tumours labelled with MPIO 
A) GFP-expressing SK-N-AS cells (green) 24 h post labelling with 20 µM MPIO (Suncoast 
Yellow Encapsulated Magnetic Polymers - Bangs Beads, red). Scale bar is 20 µm. B) Single 
channel and overlay image of neuroblastoma tumour post dissection formed by GFP-
expressing SK-N-AS cells (green) which were labelled with MPIO (red) 48h prior CAM 
implantation. Scale bar is 1000 µm. C) Representative sagittal T2W and T2*W FLASH MR 
images of embryonated chicken egg at E14 (A). Tumour formed by cells labelled with MPIO 
can be identified on top of the CAM (zoom in inset). Scale bar is 1000 µm. D) Representative 
image of tumour formed on the CAM by GFP-expressing SK-N-AS cells (green) labelled with 
MPIO (red). Nuclei are stained with Hoechst (blue). Inset shows MPIO only (red). Right image 
is 2.5xzoom. Scale bar is 100 µm. E) Comparison of tumour volume [mm3] measured by 
microscopy or MRI. Tumours 1-2 were formed by cells without MPIO, tumours 3-8 were 
formed by cells with MPIO. 
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Figure 3: MR images of cell deposits and metastasis in the chick embryo organs 
A) Representative sagittal T2W and T2*W FLASH MR images of E14 chick embryo in ovo. 
Deposit formed by cells labelled with MPIO can be identified in the brain (zoom in inset) Scale 
bar is 1000 µm. B) Representative fluorescence microscopy image of brain slice showing 
cluster of GFP and MPIO labelled neuroblastoma cells, and zoom. Scale bar is 100 µm. C) 
Representative sagittal T2W and T2*W FLASH MR images of E14 chick embryo in ovo. Shown 
are two slices of the abdominal region and kidneys. Arrows indicate signal loss that intensified 
in the T2*W FLASH sequence and thus indicates the potential presence of metastasis. D) 
Representative fluorescence microscopy image of kidney slices showing metastatic deposit 
of GFP and MPIO labelled neuroblastoma cells. Scale bar is 100 µm. E) Representative 
sagittal T2W and T2*W FLASH MR images of E14 chick embryo in ovo overlayed with ToF 
MRA (red). 
 
Supplemental information: 
Supplemental Figure 1 is related to Figure 3A and displays the signal to noise and contrast to 
noise ratios for different regions of MR images acquired by T2W and T2*W FLASH. 
